Related Experiment Videos
Streptococcus bovis meningitis in a neonate.
American Journal of Diseases of Children (1960)
|November 1, 1979
Summary
Neonatal meningitis caused by Streptococcus bovis requires careful antibiotic selection. Some strains resist penicillin, necessitating combined penicillin and aminoglycoside therapy until susceptibility is confirmed.
Area of Science:
- Microbiology
- Neonatal Medicine
- Infectious Diseases
Background:
- Neonatal infections pose significant risks to newborns.
- Streptococcus bovis, a group D Streptococcus, can cause serious neonatal infections like meningitis.
- Traditional treatment often relies on penicillin.
Observation:
- A recent case of neonatal meningitis due to Streptococcus bovis prompted a review of antibiotic strategies.
- Literature suggests penicillin monotherapy for S. bovis meningitis.
- However, penicillin-resistant strains of S. bovis have been identified, similar to enterococci.
Findings:
- Some Streptococcus bovis strains exhibit resistance to the bactericidal effects of penicillin.
- Combined therapy with penicillin and an aminoglycoside is recommended initially.
- This approach is advised until minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) testing confirms susceptibility.
Implications:
- Physicians must be aware of potential penicillin resistance in neonatal S. bovis infections.
- Initial dual antibiotic therapy can improve outcomes in meningitis cases with uncertain susceptibility.
- Tailoring antibiotic therapy based on MIC/MBC results is crucial for effective treatment and preventing resistance.